CELLULAR SIGNALLING-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2207022, encodeId=04a4220e0225e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：细胞信号通路 经验分享：投了一篇生信分析+预后标志物+实验验证 5.23投 5.24拒稿，说是因为没有在蛋白层面做验证 隔天给了5个转投期刊，其中两个保证送外审 期刊效率很高，拒稿不拖拉哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74dd8748866, createdName=ms9000000703365901, createdTime=Tue May 28 14:21:55 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206891, encodeId=f1e92206891cd, content=投稿时把通讯作者默认为一作了，而manuscript作者顺序正确，这样会有问题么？论文已接收，用不用发邮件告知编辑投稿系统的顺序与正文不一致？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Mon May 27 16:26:58 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206343, encodeId=a7e5220634309, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：不错的杂志，3月初投，4月初大修两个月，三个审稿人，4月底修回有两个实验没法补没设备，5月上旬接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Thu May 23 23:44:28 CST 2024, time=2024-05-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2202262, encodeId=11e8220226208, content=偏重的研究方向：细胞生物学 经验分享：24.3.7投稿 24.3.22返回一审意见，大修，给2个月 24.4.20提交返修稿 24.5.7接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue May 07 17:29:25 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199868, encodeId=4aca2199868f1, content=请问一审返修后，二审多久返回结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Apr 22 23:06:36 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔)]

2024-05-28 ms9000000703365901 来自湖北省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：细胞信号通路
经验分享：投了一篇生信分析+预后标志物+实验验证
5.23投
5.24拒稿，说是因为没有在蛋白层面做验证
隔天给了5个转投期刊，其中两个保证送外审
期刊效率很高，拒稿不拖拉哈哈

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2207022, encodeId=04a4220e0225e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：细胞信号通路 经验分享：投了一篇生信分析+预后标志物+实验验证 5.23投 5.24拒稿，说是因为没有在蛋白层面做验证 隔天给了5个转投期刊，其中两个保证送外审 期刊效率很高，拒稿不拖拉哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74dd8748866, createdName=ms9000000703365901, createdTime=Tue May 28 14:21:55 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206891, encodeId=f1e92206891cd, content=投稿时把通讯作者默认为一作了，而manuscript作者顺序正确，这样会有问题么？论文已接收，用不用发邮件告知编辑投稿系统的顺序与正文不一致？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Mon May 27 16:26:58 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206343, encodeId=a7e5220634309, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：不错的杂志，3月初投，4月初大修两个月，三个审稿人，4月底修回有两个实验没法补没设备，5月上旬接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Thu May 23 23:44:28 CST 2024, time=2024-05-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2202262, encodeId=11e8220226208, content=偏重的研究方向：细胞生物学 经验分享：24.3.7投稿 24.3.22返回一审意见，大修，给2个月 24.4.20提交返修稿 24.5.7接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue May 07 17:29:25 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199868, encodeId=4aca2199868f1, content=请问一审返修后，二审多久返回结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Apr 22 23:06:36 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔)]

2024-05-27 jeinne 来自辽宁省

投稿时把通讯作者默认为一作了，而manuscript作者顺序正确，这样会有问题么？论文已接收，用不用发邮件告知编辑投稿系统的顺序与正文不一致？

2 0

[GetPortalCommentsPageByObjectIdResponse(id=2207022, encodeId=04a4220e0225e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：细胞信号通路 经验分享：投了一篇生信分析+预后标志物+实验验证 5.23投 5.24拒稿，说是因为没有在蛋白层面做验证 隔天给了5个转投期刊，其中两个保证送外审 期刊效率很高，拒稿不拖拉哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74dd8748866, createdName=ms9000000703365901, createdTime=Tue May 28 14:21:55 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206891, encodeId=f1e92206891cd, content=投稿时把通讯作者默认为一作了，而manuscript作者顺序正确，这样会有问题么？论文已接收，用不用发邮件告知编辑投稿系统的顺序与正文不一致？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Mon May 27 16:26:58 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206343, encodeId=a7e5220634309, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：不错的杂志，3月初投，4月初大修两个月，三个审稿人，4月底修回有两个实验没法补没设备，5月上旬接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Thu May 23 23:44:28 CST 2024, time=2024-05-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2202262, encodeId=11e8220226208, content=偏重的研究方向：细胞生物学 经验分享：24.3.7投稿 24.3.22返回一审意见，大修，给2个月 24.4.20提交返修稿 24.5.7接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue May 07 17:29:25 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199868, encodeId=4aca2199868f1, content=请问一审返修后，二审多久返回结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Apr 22 23:06:36 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔)]

2024-05-23 ms4000000135716353 来自上海

审稿速度:1.0 | 投稿命中率:50.0
经验分享：不错的杂志，3月初投，4月初大修两个月，三个审稿人，4月底修回有两个实验没法补没设备，5月上旬接收

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2207022, encodeId=04a4220e0225e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：细胞信号通路 经验分享：投了一篇生信分析+预后标志物+实验验证 5.23投 5.24拒稿，说是因为没有在蛋白层面做验证 隔天给了5个转投期刊，其中两个保证送外审 期刊效率很高，拒稿不拖拉哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74dd8748866, createdName=ms9000000703365901, createdTime=Tue May 28 14:21:55 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206891, encodeId=f1e92206891cd, content=投稿时把通讯作者默认为一作了，而manuscript作者顺序正确，这样会有问题么？论文已接收，用不用发邮件告知编辑投稿系统的顺序与正文不一致？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Mon May 27 16:26:58 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206343, encodeId=a7e5220634309, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：不错的杂志，3月初投，4月初大修两个月，三个审稿人，4月底修回有两个实验没法补没设备，5月上旬接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Thu May 23 23:44:28 CST 2024, time=2024-05-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2202262, encodeId=11e8220226208, content=偏重的研究方向：细胞生物学 经验分享：24.3.7投稿 24.3.22返回一审意见，大修，给2个月 24.4.20提交返修稿 24.5.7接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue May 07 17:29:25 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199868, encodeId=4aca2199868f1, content=请问一审返修后，二审多久返回结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Apr 22 23:06:36 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔)]

2022-10-22 ms2000000321618143

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：生物信息学
经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！

59 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207022, encodeId=04a4220e0225e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：细胞信号通路 经验分享：投了一篇生信分析+预后标志物+实验验证 5.23投 5.24拒稿，说是因为没有在蛋白层面做验证 隔天给了5个转投期刊，其中两个保证送外审 期刊效率很高，拒稿不拖拉哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74dd8748866, createdName=ms9000000703365901, createdTime=Tue May 28 14:21:55 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206891, encodeId=f1e92206891cd, content=投稿时把通讯作者默认为一作了，而manuscript作者顺序正确，这样会有问题么？论文已接收，用不用发邮件告知编辑投稿系统的顺序与正文不一致？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Mon May 27 16:26:58 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206343, encodeId=a7e5220634309, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：不错的杂志，3月初投，4月初大修两个月，三个审稿人，4月底修回有两个实验没法补没设备，5月上旬接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Thu May 23 23:44:28 CST 2024, time=2024-05-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2202262, encodeId=11e8220226208, content=偏重的研究方向：细胞生物学 经验分享：24.3.7投稿 24.3.22返回一审意见，大修，给2个月 24.4.20提交返修稿 24.5.7接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue May 07 17:29:25 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199868, encodeId=4aca2199868f1, content=请问一审返修后，二审多久返回结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Apr 22 23:06:36 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔)]

2024-05-07 ms4000001668897773 来自北京

偏重的研究方向：细胞生物学
经验分享：24.3.7投稿 24.3.22返回一审意见，大修，给2个月 24.4.20提交返修稿 24.5.7接收

8 0

[GetPortalCommentsPageByObjectIdResponse(id=2207022, encodeId=04a4220e0225e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：细胞信号通路 经验分享：投了一篇生信分析+预后标志物+实验验证 5.23投 5.24拒稿，说是因为没有在蛋白层面做验证 隔天给了5个转投期刊，其中两个保证送外审 期刊效率很高，拒稿不拖拉哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74dd8748866, createdName=ms9000000703365901, createdTime=Tue May 28 14:21:55 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206891, encodeId=f1e92206891cd, content=投稿时把通讯作者默认为一作了，而manuscript作者顺序正确，这样会有问题么？论文已接收，用不用发邮件告知编辑投稿系统的顺序与正文不一致？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Mon May 27 16:26:58 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206343, encodeId=a7e5220634309, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：不错的杂志，3月初投，4月初大修两个月，三个审稿人，4月底修回有两个实验没法补没设备，5月上旬接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Thu May 23 23:44:28 CST 2024, time=2024-05-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2202262, encodeId=11e8220226208, content=偏重的研究方向：细胞生物学 经验分享：24.3.7投稿 24.3.22返回一审意见，大修，给2个月 24.4.20提交返修稿 24.5.7接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue May 07 17:29:25 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199868, encodeId=4aca2199868f1, content=请问一审返修后，二审多久返回结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Apr 22 23:06:36 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔)]

2024-04-22 ms4000001668897773 来自北京

请问一审返修后，二审多久返回结果？

7 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207022, encodeId=04a4220e0225e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：细胞信号通路 经验分享：投了一篇生信分析+预后标志物+实验验证 5.23投 5.24拒稿，说是因为没有在蛋白层面做验证 隔天给了5个转投期刊，其中两个保证送外审 期刊效率很高，拒稿不拖拉哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74dd8748866, createdName=ms9000000703365901, createdTime=Tue May 28 14:21:55 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206891, encodeId=f1e92206891cd, content=投稿时把通讯作者默认为一作了，而manuscript作者顺序正确，这样会有问题么？论文已接收，用不用发邮件告知编辑投稿系统的顺序与正文不一致？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Mon May 27 16:26:58 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206343, encodeId=a7e5220634309, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：不错的杂志，3月初投，4月初大修两个月，三个审稿人，4月底修回有两个实验没法补没设备，5月上旬接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Thu May 23 23:44:28 CST 2024, time=2024-05-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2202262, encodeId=11e8220226208, content=偏重的研究方向：细胞生物学 经验分享：24.3.7投稿 24.3.22返回一审意见，大修，给2个月 24.4.20提交返修稿 24.5.7接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue May 07 17:29:25 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199868, encodeId=4aca2199868f1, content=请问一审返修后，二审多久返回结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Apr 22 23:06:36 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔)]

2024-03-15 ms8000002086734954 来自上海

这个期刊Under review后容易接受吗？

16 0

[GetPortalCommentsPageByObjectIdResponse(id=2207022, encodeId=04a4220e0225e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：细胞信号通路 经验分享：投了一篇生信分析+预后标志物+实验验证 5.23投 5.24拒稿，说是因为没有在蛋白层面做验证 隔天给了5个转投期刊，其中两个保证送外审 期刊效率很高，拒稿不拖拉哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74dd8748866, createdName=ms9000000703365901, createdTime=Tue May 28 14:21:55 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206891, encodeId=f1e92206891cd, content=投稿时把通讯作者默认为一作了，而manuscript作者顺序正确，这样会有问题么？论文已接收，用不用发邮件告知编辑投稿系统的顺序与正文不一致？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Mon May 27 16:26:58 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206343, encodeId=a7e5220634309, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：不错的杂志，3月初投，4月初大修两个月，三个审稿人，4月底修回有两个实验没法补没设备，5月上旬接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Thu May 23 23:44:28 CST 2024, time=2024-05-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2202262, encodeId=11e8220226208, content=偏重的研究方向：细胞生物学 经验分享：24.3.7投稿 24.3.22返回一审意见，大修，给2个月 24.4.20提交返修稿 24.5.7接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue May 07 17:29:25 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199868, encodeId=4aca2199868f1, content=请问一审返修后，二审多久返回结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Apr 22 23:06:36 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔)]

2024-03-14 jeinne 来自辽宁省

投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2207022, encodeId=04a4220e0225e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：细胞信号通路 经验分享：投了一篇生信分析+预后标志物+实验验证 5.23投 5.24拒稿，说是因为没有在蛋白层面做验证 隔天给了5个转投期刊，其中两个保证送外审 期刊效率很高，拒稿不拖拉哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74dd8748866, createdName=ms9000000703365901, createdTime=Tue May 28 14:21:55 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206891, encodeId=f1e92206891cd, content=投稿时把通讯作者默认为一作了，而manuscript作者顺序正确，这样会有问题么？论文已接收，用不用发邮件告知编辑投稿系统的顺序与正文不一致？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Mon May 27 16:26:58 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206343, encodeId=a7e5220634309, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：不错的杂志，3月初投，4月初大修两个月，三个审稿人，4月底修回有两个实验没法补没设备，5月上旬接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Thu May 23 23:44:28 CST 2024, time=2024-05-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2202262, encodeId=11e8220226208, content=偏重的研究方向：细胞生物学 经验分享：24.3.7投稿 24.3.22返回一审意见，大修，给2个月 24.4.20提交返修稿 24.5.7接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue May 07 17:29:25 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199868, encodeId=4aca2199868f1, content=请问一审返修后，二审多久返回结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Apr 22 23:06:36 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔)]

2024-03-08 ms4000000135716353 来自上海

60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2207022, encodeId=04a4220e0225e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：细胞信号通路 经验分享：投了一篇生信分析+预后标志物+实验验证 5.23投 5.24拒稿，说是因为没有在蛋白层面做验证 隔天给了5个转投期刊，其中两个保证送外审 期刊效率很高，拒稿不拖拉哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74dd8748866, createdName=ms9000000703365901, createdTime=Tue May 28 14:21:55 CST 2024, time=2024-05-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2206891, encodeId=f1e92206891cd, content=投稿时把通讯作者默认为一作了，而manuscript作者顺序正确，这样会有问题么？论文已接收，用不用发邮件告知编辑投稿系统的顺序与正文不一致？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Mon May 27 16:26:58 CST 2024, time=2024-05-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2206343, encodeId=a7e5220634309, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：不错的杂志，3月初投，4月初大修两个月，三个审稿人，4月底修回有两个实验没法补没设备，5月上旬接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Thu May 23 23:44:28 CST 2024, time=2024-05-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2095327, encodeId=7456209532ef1, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：生物信息学 经验分享：很好的投稿体验！主要是做公共单细胞数据库挖掘+不到1个figure的湿实验（组化+免疫荧光），审稿速度超快，9-18左右投稿，一周左右就送审了，10-8左右给的一审意见，隔了三天修回，第二天就给二审意见，补充了一个组化，10-20左右修回，10-22今天早上看就已经accept！祝大家投稿顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8da05572124, createdName=ms2000000321618143, createdTime=Sat Oct 22 09:29:14 CST 2022, time=2022-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2202262, encodeId=11e8220226208, content=偏重的研究方向：细胞生物学 经验分享：24.3.7投稿 24.3.22返回一审意见，大修，给2个月 24.4.20提交返修稿 24.5.7接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Tue May 07 17:29:25 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2199868, encodeId=4aca2199868f1, content=请问一审返修后，二审多久返回结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Apr 22 23:06:36 CST 2024, time=2024-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193511, encodeId=1fb6219351155, content=这个期刊Under review后容易接受吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4e68507311, createdName=ms8000002086734954, createdTime=Fri Mar 15 22:58:04 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193257, encodeId=a64a219325ef8, content=投稿20天后，状态从 Under review变成 required reviewer completed，第二天又变回under review，代表什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=018e1612958, createdName=jeinne, createdTime=Thu Mar 14 19:02:49 CST 2024, time=2024-03-14, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192107, encodeId=7743219210ed8, content=60天稿号到了500…… 一年也就300多篇，接收率没有官网给的22%那么高呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3b15688005, createdName=ms4000000135716353, createdTime=Fri Mar 08 16:10:40 CST 2024, time=2024-03-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147806, encodeId=005b214e806e4, content=偏重的研究方向：心血管疾病 经验分享：这个杂志是不是 submit to the journal后立即就under review了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJowicLVgt4uscELibnHsWdmOSt7ADiaGcBSAYFsiccbpaxW1rwicywrcjE9tTq1pic9vp2sibRpxzo1e4Zg/0, createdBy=92272143173, createdName=bana, createdTime=Thu Jul 13 10:13:14 CST 2023, time=2023-07-13, status=1, ipAttribution=首尔)]

2023-07-13 bana 来自首尔

偏重的研究方向：心血管疾病
经验分享：这个杂志是不是 submit to the journal后立即就under review了？

57 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务